genetic testing

Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.
Four ways genetic testing is changing cancer careJust as cancer takes many forms, so does genetic testing. Here’s what you need to know.
Genetic testing in oncology: 5 things payers should knowAs genomics continues to evolve, here are five things to know about genetic testing and counseling.
Is genetic testing for cancer survivors underutilized?One study looks at whether or not women with histories of breast or ovarian cancer are receiving necessary genetic testing. Plus: Can in-office hysteroscopy reliably evaluate uterine pathology? Also, researchers say mammographic density changes should be monitored in patients undergoing hormone therapy as a possible indicator of breast cancer.
Health plans explain genetic testing coverage decisions
Health plans explain genetic testing coverage decisionsToday there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.
Nystagmus diagnosis begins with thorough eye examA careful clinical workup, along with genetic testing, can help pinpoint what is behind congenital and infantile nystagmus.
Personalized medicine brings big wins to managed careA new report reveals how personalized medicine can make patients healthier while lowering costs.
Failure to recommend genetic testing in breast cancerIs this the next wave of medical professional liability lawsuits?
Genetic testing initiative for inherited retinal diseases shows great promiseI have been encouraged as a retinal specialist with all the excitement and promising new treatments in gene therapy. Given that there are several retinal diseases with known inherited patterns and confirmed genetic loci responsible for the clinical manifestations, our field is primed to benefit from the expansion of knowledge in this arena.